0

FOCUS

The Journal of Lifelong Learning in Psychiatry Editors: Deborah J. Hales, M.D. and Mark Hyman Rapaport, M.D.
CLINICAL SYNTHESIS  |  April 1, 2014
New Options for the Treatment of Schizophrenia: A Clinical Review of the Three Most Recent Antipsychotic Drugs

This clinical review summarizes the pharmacological characteristics, efficacy, and tolerability of asenapine, iloperidone, and lurasidone, the most recently approved antipsychotics in the treatment of schizophrenia.

CLINICAL SYNTHESIS  |  April 1, 2014
Psychopharmacology of Bipolar II Depression and Bipolar Depression with Mixed Features

In this article we focus on the aspects of BD that are difficult to treat clinically and that lie outside most research to date, but nonetheless represent a significant illness burden: BD II depression and BD depression with mixed features.

CLINICAL SYNTHESIS  |  April 1, 2014
Advances in Psychopharmacology for Anxiety Disorders

Anxiety disorders are among the most prevalent psychiatric disorders, but compared with mood and psychotic disorders, are understudied in terms of newer pharmacotherapeutic approaches. Here we will review the most recent pharmacological treatment modalities under investigation for anxiety disorders and related conditions such as PTSD.

View Current Issue Contents >
Take the 2013 Self-Assessment